Financials
- Market Capitalization 440.14 M
- Employee 48
- Founded 2020
- CEO N/A
- Website www.evommune.com
- Headquarter Delaware, United States
- FIGI BBG00Y79N887
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-1.53
売上高対価格比率
8.08
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3008 | SLN Silence Therapeutics Plc - American Depository Share | 9.36 USD | +0.75% | -12.77% | +37.85% | +48.10% | 442.12 M USD | ||
| 3010 | VALN Valneva SE - American Depositary Shares | 5.09 USD | -3.23% | -3.23% | -6.95% | -22.05% | 441.66 M USD | ||
| 3015 | SGMT Sagimet Biosciences Inc. - Series A Common Stock | 7.12 USD | -0.42% | -7.77% | +8.54% | -24.26% | 439.67 M USD | ||
| 3037 | CCCC C4 Therapeutics, Inc. - Common Stock | 3.89 USD | -0.77% | -10.37% | -2.26% | +63.45% | 430.11 M USD |